1. Early leukemia diagnostics
28-05-2013
Sergey Zasukhin zasukhin@immunoslide.com

2. Leukemia
Leading cause of death among children under 15
250 000 deaths per year
350 000 new cases
per year

3. The disease is detected TOO LATE
Common methods of leukemia diagnostics are
NOT SENSITIVE ENOUGH
ONLY 4% are diagnosed at the stage of
preventive inspection
Problem

4. ImmunoSlide
Affordable price
High accuracy

5. Sensitive
Y Y Y Y
Antigen
Immobilized
antibody
Blood cell
Immunoslide
gives 10 TIMES HIGHER CHANCE of finding leukemia at it’s early stage
Devise for early leukemia diagnostics.
Affordable
CD 4 CD 4 CD 8 CD 8
Immunoslide

7. Advisors
Fazly Ataullakhanov, Member of the National Biochemical Society of Russia
(1975) and Member of the Biophysical Society of USA (1997), Editorial
board of “Biologicheskie Membrany” (1989), Member of the Science
Council of Institute for Chemical Biophysics (1997), Editorial Board of Open
Journal of Structural Biology, Bentham Pub, USA and Journal of Biophysics
(open access) (2007), Member of Academy of the Natural Sciences..
Igor Pivovarov, Member of the directors board of several companies.
Experience in realization of innovative projects - 5 years, participated
in 7 innovative projects, work experience as CTO, CMO, CEO. Obtained
about 660 mln. roubles of investments. The last project - LLC
“HemaCore” was created with invesment from RUSNANO, in that
project the unique medical diagnostic equipment for blood system
coagulation is being developed, produced and gone through clinical
trials. Has the unique experience in the biotechnological projects
commercialization.

8. Immuno
Slide
Flow
cytometry
Immunocit
ochemistry
Blood
smear
Morphological analysis ++ -- - +
Immunophenotyping + ++ + --
Cost of one test 6$ 10 – 30$ 20 – 40$ 3$
Cost of equipment 7 000$ 100 000$ - -
Duration of analysis 1,5 hour 0,5 hour 3 hours 0,5 hour
Simplicity of exploitation + -- -- +
Competitors

9. Russian market
PRIVATE
MARKET
GOVERNMENTAL MARKET

10. Thank you for your attention!
mail@immunoslide.com
Q&A?